If you notice any of the following, contact your doctor immediately: Unexplained bruising or "purplish" patches on the skin
Jan 16, 2026 The Science of Copper Peptides and Hair Regrowth Your hair follicles are dying
Some forward-thinking employers now include wellness benefits that may cover a portion of IV therapy costs
Retatrutide Clinical Research Findings The clinical development program for retatrutide has produced compelling data across multiple research endpoints: Weight Loss Efficacy: Phase 2 trials showed dose-dependent weight reduction ranging from 8.7% at the lowest dose to 24.2% at the highest dose over 48 weeks Metabolic Improvements: Participants demonstrated improvements in glycemic control, lipid profiles, and blood pressure measurements Safety Profile: Gastrointestinal effects (nausea, vomiting, diarrhea) were the most common adverse events, occurring in 60-80% of participants but generally rated as mild to moderate in severity Sustained Effects: Weight loss continued throughout the trial period without evidence of plateau, suggesting ongoing metabolic benefits These findings have positioned retatrutide as a leading candidate for advanced metabolic research

For researchers using oral capsules, taking the compound 30 to 60 minutes before meals in a fasted state may enhance fat oxidation effects, though this recommendation is based on theoretical considerations rather than controlled studies
By addressing B12 deficiency, promoting a healthy immune response, and alleviating associated symptoms, Vitamin B12 injections offer a glimmer of hope for cats suffering from FIP